MoonLake Immunotherapeutics
MLTX
MLTX
125 hedge funds and large institutions have $3.53B invested in MoonLake Immunotherapeutics in 2023 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 51 increasing their positions, 33 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
125
Holders Change
+7
Holders Change %
+5.93%
% of All Funds
1.83%
Holding in Top 10
6
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-40%
% of All Funds
0.09%
New
37
Increased
51
Reduced
33
Closed
28
Calls
$39.7M
Puts
$47.3M
Net Calls
-$7.57M
Net Calls Change
+$48.7M
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
151
US Bancorp
Minneapolis,
Minnesota
| – | -$202K | -3,547 | Closed |
|
|
DWA
152
Dorsey Wright & Associates
Pasadena,
California
| – | -$61.2K | -1,074 | Closed |
|
|
SPIA
153
Steward Partners Investment Advisory
New York
| – | -$11.4K | -200 | Closed |
|